• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

供体卵母细胞计划中卵泡抽吸后使用促性腺激素释放激素激动剂——对后续月经的影响

Use of gonadotropin releasing hormone agonist following follicular aspiration in donor oocyte program--impact on subsequent menstruation.

作者信息

Ng S T, Wu T C

机构信息

Department of Obstetrics and Gynecology, School of Medicine, University of California at Los Angeles, USA.

出版信息

Int J Fertil Menopausal Stud. 1995 Jan-Feb;40(1):29-33.

PMID:7749432
Abstract

OBJECTIVE

The present study evaluated the impact of continuous administration of gonadotropin-releasing hormone agonist (GnRH-a) following oocyte retrieval of oocyte donors in a donor oocyte program.

PATIENTS AND METHODS

Six patients from a donor oocyte program who underwent controlled ovarian hyperstimulation with midluteal GnRH-a and human menotropin had more than 20 mature ovarian follicles and serum estradiol levels > or = 3,000 pg/mL on the day of human chorionic gonadotropin administration. These patients resumed the use of GnRH-a immediately following follicular aspiration. Three patients continued daily injection until the onset of next menses, while three took it irregularly, due to poor compliance.

RESULTS

Only one of the three patients who administered GnRH-a daily developed mild symptoms of ovarian hyperstimulation, and all resumed menstruation within 13 days following aspiration. All three patients who failed to comply, and used GnRH-a sporadically, developed symptoms of ovarian hyperstimulation and experienced delayed menstrual periods. One of these three patients required hospitalization.

CONCLUSION

Our data suggest that continuous postaspiration GnRH-a use may be beneficial for oocyte donors whose ovaries are hyperstimulated. Sporadic administration of GnRH-a is not effective and may delay the resumption of spontaneous menstruation.

摘要

目的

本研究评估了在供卵项目中,卵母细胞供者取卵后持续使用促性腺激素释放激素激动剂(GnRH-a)的影响。

患者与方法

来自一个供卵项目的6名患者,在黄体中期使用GnRH-a和人促性腺激素进行控制性卵巢过度刺激,在注射人绒毛膜促性腺激素当天有超过20个成熟卵泡且血清雌二醇水平≥3000 pg/mL。这些患者在卵泡抽吸后立即恢复使用GnRH-a。3名患者持续每日注射直至下次月经来潮,而另外3名患者由于依从性差,不规则用药。

结果

每日使用GnRH-a的3名患者中只有1名出现轻度卵巢过度刺激症状,且所有人在抽吸后13天内恢复月经。所有3名未依从且偶尔使用GnRH-a的患者出现卵巢过度刺激症状且月经推迟。这3名患者中有1名需要住院治疗。

结论

我们的数据表明,取卵后持续使用GnRH-a可能对卵巢过度刺激的卵母细胞供者有益。偶尔使用GnRH-a无效,且可能延迟自然月经的恢复。

相似文献

1
Use of gonadotropin releasing hormone agonist following follicular aspiration in donor oocyte program--impact on subsequent menstruation.供体卵母细胞计划中卵泡抽吸后使用促性腺激素释放激素激动剂——对后续月经的影响
Int J Fertil Menopausal Stud. 1995 Jan-Feb;40(1):29-33.
2
Preventing severe ovarian hyperstimulation syndrome in an in vitro fertilization/embryo transfer program. Use of follicular aspiration after human chorionic gonadotropin administration.
J Reprod Med. 1995 Jan;40(1):37-40.
3
Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.在多囊卵泡发育病例中,低剂量人绒毛膜促性腺激素用于GnRH激动剂触发排卵后黄体支持的安全性和有效性。
Eur J Obstet Gynecol Reprod Biol. 2006 May 1;126(1):87-92. doi: 10.1016/j.ejogrb.2005.11.013. Epub 2005 Dec 22.
4
Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: impact of gonadotropin-releasing hormone agonists versus antagonists.在使用控制性卵巢过度刺激的周期黄体期子宫内膜成熟加速:促性腺激素释放激素激动剂与拮抗剂的影响
Fertil Steril. 2004 Jul;82(1):167-71. doi: 10.1016/j.fertnstert.2003.11.050.
5
Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression.慢性促性腺激素释放激动剂给药后多囊卵巢疾病的口服避孕药治疗。持续卵巢抑制的预测因素。
J Reprod Med. 1996 Sep;41(9):645-52.
6
Midcycle administration of single-dose GnRHa for luteal phase failure in women with ovarian hyperstimulation. A report of five cases.单剂量促性腺激素释放激素激动剂(GnRHa)在月经周期中期给药治疗卵巢过度刺激综合征女性黄体期缺陷:5例报告
J Reprod Med. 2000 Feb;45(2):156-8.
7
Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.多囊卵巢女性接受体外受精治疗时,与使用人绒毛膜促性腺激素相比,使用促性腺激素释放激素激动剂触发卵母细胞成熟后的血清抑制素A、血管内皮生长因子和肿瘤坏死因子α水平:一项前瞻性随机试验
Hum Reprod. 2006 May;21(5):1260-5. doi: 10.1093/humrep/dei475. Epub 2006 Jan 26.
8
Ovarian estradiol production in vivo. Inhibitory effect of leuprolide acetate.体内卵巢雌二醇的产生。醋酸亮丙瑞林的抑制作用。
J Reprod Med. 1998 May;43(5):413-7.
9
Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.通过停用促性腺激素和促性腺激素释放激素激动剂进行1至2天的短暂减药,可预防卵巢过度刺激综合征,且不影响治疗效果。
Fertil Steril. 2008 Dec;90(6):2172-8. doi: 10.1016/j.fertnstert.2007.10.033. Epub 2008 Apr 25.
10
A prospective trial comparing oocyte donor ovarian response and recipient pregnancy rates between suppression with gonadotrophin-releasing hormone agonist (GnRHa) alone and dual suppression with a contraceptive vaginal ring and GnRH.
Hum Reprod. 2006 Aug;21(8):2121-5. doi: 10.1093/humrep/del121. Epub 2006 Apr 21.